On November 11, 2025, GSK plc purchased 167,000 of its ordinary shares at prices ranging from 1,791.50p to 1,825.00p as part of its ongoing buyback program, totaling 8,496,000 shares bought since September 30, 2025. The company now holds 255,960,844 shares in treasury and has 4,059,467,530 shares in issue, giving a treasury share voting rights percentage of 6.31%.